| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |